NCT01655082View on ClinicalTrials.gov

Nicotine Patch Safety Study

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Smokers
Interventions
DRUG

V0116 transdermal patch

One patch per day (during 24 hours) for 21 days

DRUG

Nicotine transdermal patch

One patch per day (during 24 hours) for 21 days

Trial Locations (4)

Unknown

Gières

Pierre-Bénite

Rennes

Rueil-Malmaison

All Listed Sponsors
lead

Pierre Fabre Medicament

INDUSTRY

NCT01655082 - Nicotine Patch Safety Study | Biotech Hunter | Biotech Hunter